Keros Therapeutics (KROS) Cash from Financing Activities (2019 - 2025)
Keros Therapeutics posted quarterly Cash from Financing Activities of -$378.6 million for Q4 2025, down 601.21% year-on-year from $75.5 million in Q4 2024, and down 270550.71% on a QoQ basis from $140000.0 in Q3 2025.
Keros Therapeutics (KROS) has 7 years of Cash from Financing Activities data on file, last reported at -$378.6 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities fell 601.21% year-over-year to -$378.6 million; the trailing twelve-month figure through Dec 2025 stood at -$378.5 million (down 196.59% YoY), and the FY2025 full-year result was -$378.5 million, down 196.59% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at -$378.6 million, down from $140000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $156.8 million in Q1 2024 and bottomed at -$378.6 million in Q4 2025.
- The 5-year median for Cash from Financing Activities is $2.6 million (2023), against an average of $17.1 million.
- The widest annual swing landed in 2022, when Cash from Financing Activities jumped 138708.57%; it then slumped 601.21% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $28.4 million in 2021, then jumped by 116.13% to $61.4 million in 2022, then advanced by 12.76% to $69.3 million in 2023, then advanced by 9.08% to $75.5 million in 2024, then plunged by 601.21% to -$378.6 million in 2025.
- The last three Cash from Financing Activities figures came in at -$378.6 million (Q4 2025), $140000.0 (Q3 2025), and $17000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Keros Therapeutics | 403.85 Mn | 116.45 Mn | - | -378.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -378.63 Mn |
| Dec 31, 2025 | -378.63 Mn |
| Sep 30, 2025 | 140,000.00 |
| Sep 30, 2025 | 140,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Mar 31, 2025 | 4,000.00 |
| Dec 31, 2024 | 75.54 Mn |
| Dec 31, 2024 | 75.54 Mn |
| Sep 30, 2024 | 155.94 Mn |
| Sep 30, 2024 | 155.94 Mn |
| Jun 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 3.53 Mn |
| Mar 31, 2024 | 156.80 Mn |
| Mar 31, 2024 | 156.80 Mn |
| Dec 31, 2023 | 69.25 Mn |
| Dec 31, 2023 | 69.25 Mn |
| Sep 30, 2023 | 284,000.00 |
| Sep 30, 2023 | 284,000.00 |
| Jun 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 1.74 Mn |
| Mar 31, 2023 | 107.68 Mn |
| Mar 31, 2023 | 107.68 Mn |
| Dec 31, 2022 | 61.42 Mn |
| Dec 31, 2022 | 61.42 Mn |
| Sep 30, 2022 | 48.58 Mn |
| Sep 30, 2022 | 48.58 Mn |
| Jun 30, 2022 | 10.19 Mn |
| Jun 30, 2022 | 10.19 Mn |
| Mar 31, 2022 | 118,000.00 |
| Mar 31, 2022 | 118,000.00 |
| Dec 31, 2021 | 28.42 Mn |
| Dec 31, 2021 | 28.42 Mn |
| Sep 30, 2021 | 35,000.00 |
| Sep 30, 2021 | 35,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Jun 30, 2021 | 57,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Mar 31, 2021 | 42,000.00 |
| Dec 31, 2020 | 140.12 Mn |
| Dec 31, 2020 | 140.12 Mn |
| Sep 30, 2020 | 9,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 100.12 Mn |
| Jun 30, 2020 | 100.12 Mn |
| Mar 31, 2020 | 55.79 Mn |
| Mar 31, 2020 | 55.79 Mn |
| Dec 31, 2019 | 4,000.00 |
| Dec 31, 2019 | 4,000.00 |
| Sep 30, 2019 | 6,000.00 |
| Sep 30, 2019 | 6,000.00 |
| Jun 30, 2019 | 4,000.00 |
| Jun 30, 2019 | 4,000.00 |